Back to CVE records
Critical 9.9Published Aug 10, 2026

CVE-2026-72867Dokploy: Incomplete fix of CVE-2026-45628: Command Injection via Unvalidated Branch Fields in Compose Deployment Pipeline (server-side regex missing in compose.ts)

Updated under an hour ago ()

Does this affect you?

It affects dokploy. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Dokploy is a free, self-hostable Platform as a Service (PaaS). From 0.29.3 until 0.29.13, the incomplete fix for CVE-2026-45628 leaves packages/server/src/db/schema/compose.ts branch fields without server-side validation, allowing a direct compose.update request to store a malicious customGitBranch, branch, gitlabBranch, bitbucketBranch, or giteaBranch. A low-privileged authenticated user can trigger compose.deploy, which passes the stored branch to shell-based Git clone commands in packages/server/src/utils/providers/git.ts, github.ts, gitlab.ts, bitbucket.ts, and gitea.ts, resulting in arbitrary host command execution. This issue is fixed in version 0.29.13.

CVSS
9.9 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Weakness (CWE)
CWE-20, CWE-78, CWE-602
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Aug 13, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Dokploy dokploy
dokploy:dokploy (from the name)
from 0.29.3, < 0.29.13
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.